These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 30784041)

  • 1. High-density lipoprotein lipid peroxidation as a molecular signature of the risk for developing cardiovascular disease: Results from MASHAD cohort.
    Samadi S; Mehramiz M; Kelesidis T; Mobarhan MG; Sahebkar AH; Esmaily H; Moohebati M; Farjami Z; Ferns GA; Mohammadpour AH; Avan A
    J Cell Physiol; 2019 Sep; 234(9):16168-16177. PubMed ID: 30784041
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Rare P376L variant in the SR-BI gene associates with HDL dysfunction and risk of cardiovascular disease.
    Samadi S; Farjami Z; Hosseini ZS; Ferns GA; Mohammadpour AH; Tayefi M; Fal-Soleiman H; Moohebati M; Ghayour-Mobarhan M; Esmaily H; Avan A
    Clin Biochem; 2019 Nov; 73():44-49. PubMed ID: 31251897
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Human T lymphotropic virus type 1 and risk of cardiovascular disease: High-density lipoprotein dysfunction versus serum HDL-C concentrations.
    Samadi S; Abolbashari S; Meshkat Z; Mohammadpour AH; Kelesidis T; Gholoobi A; Mehramiz M; Tabadkani M; Sadabadi F; Dalirfardouei R; Ferns GA; Ghayour-Mobarhan M; Avan A
    Biofactors; 2019 May; 45(3):374-380. PubMed ID: 30693992
    [TBL] [Abstract][Full Text] [Related]  

  • 4. High-density lipoprotein lipid peroxidation as a diagnostics biomarker in coronary artery disease.
    Yazdandoust S; Parizadeh SMR; Ghayour-Mobarhan M; Yaghmaei P; Sahebkar AH
    Biofactors; 2022 May; 48(3):634-642. PubMed ID: 35080064
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Predictors of Impaired HDL Function in HIV-1 Infected Compared to Uninfected Individuals.
    Kelesidis T; Oda MN; Borja MS; Yee Y; Ng KF; Huynh D; Elashoff D; Currier JS
    J Acquir Immune Defic Syndr; 2017 Jul; 75(3):354-363. PubMed ID: 28346318
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dyslipidemia and cardiovascular disease risk among the MASHAD study population.
    Hedayatnia M; Asadi Z; Zare-Feyzabadi R; Yaghooti-Khorasani M; Ghazizadeh H; Ghaffarian-Zirak R; Nosrati-Tirkani A; Mohammadi-Bajgiran M; Rohban M; Sadabadi F; Rahimi HR; Ghalandari M; Ghaffari MS; Yousefi A; Pouresmaeili E; Besharatlou MR; Moohebati M; Ferns GA; Esmaily H; Ghayour-Mobarhan M
    Lipids Health Dis; 2020 Mar; 19(1):42. PubMed ID: 32178672
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Soluble levels of receptor for advanced glycation endproducts and dysfunctional high-density lipoprotein in persons infected with human immunodeficiency virus: ACTG NWCS332.
    Kelesidis T; Kendall MA; Danoff A; Aberg JA; Currier JS; Schmidt AM
    Medicine (Baltimore); 2018 Jun; 97(22):e10955. PubMed ID: 29851842
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Association Between rs1748195 and rs11207997 Variants of the ANGPTL3 Gene and Susceptibility to Cardiovascular Disease in the MASHAD Cohort Study.
    Aghasizadeh M; Safarian H; Haqhani M; Avan A; Kazemi T; Ferns GA; Esmaily H; Miri-Moghaddam E; Ghayour-Mobarhan M
    Biochem Genet; 2022 Apr; 60(2):738-754. PubMed ID: 34417926
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cholesterol Efflux Capacity, High-Density Lipoprotein Particle Number, and Incident Cardiovascular Events: An Analysis From the JUPITER Trial (Justification for the Use of Statins in Prevention: An Intervention Trial Evaluating Rosuvastatin).
    Khera AV; Demler OV; Adelman SJ; Collins HL; Glynn RJ; Ridker PM; Rader DJ; Mora S
    Circulation; 2017 Jun; 135(25):2494-2504. PubMed ID: 28450350
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lipid measures for prediction of incident cardiovascular disease in diabetic and non-diabetic adults: results of the 8.6 years follow-up of a population based cohort study.
    Tohidi M; Hatami M; Hadaegh F; Safarkhani M; Harati H; Azizi F
    Lipids Health Dis; 2010 Jan; 9():6. PubMed ID: 20096127
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dysfunctional high-density lipoprotein from HIV+ individuals promotes monocyte-derived foam cell formation in vitro.
    Angelovich TA; Hearps AC; Oda MN; Borja MS; Huynh D; Homann S; Jaworowski A; Kelesidis T
    AIDS; 2017 Nov; 31(17):2331-2336. PubMed ID: 28926407
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Serum HDL cholesterol uptake capacity in subjects from the MASHAD cohort study: Its value in determining the risk of cardiovascular endpoints.
    Aghasizadeh M; Samadi S; Sahebkar A; Miri-Moghaddam E; Esmaily H; Souktanloo M; Avan A; Mansoori A; Ferns GA; Kazemi T; Ghayour-Mobarhan M
    J Clin Lab Anal; 2021 Jun; 35(6):e23770. PubMed ID: 34028874
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cell-free Biochemical Fluorometric Enzymatic Assay for High-throughput Measurement of Lipid Peroxidation in High Density Lipoprotein.
    Sen Roy S; Nguyen HCX; Angelovich TA; Hearps AC; Huynh D; Jaworowski A; Kelesidis T
    J Vis Exp; 2017 Oct; (128):. PubMed ID: 29053671
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Association of the serum myeloperoxidase/high-density lipoprotein particle ratio and incident cardiovascular events in a multi-ethnic population: Observations from the Dallas Heart Study.
    Khine HW; Teiber JF; Haley RW; Khera A; Ayers CR; Rohatgi A
    Atherosclerosis; 2017 Aug; 263():156-162. PubMed ID: 28645072
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The association between low-density and non-high-density lipoprotein cholesterol with incident cardiovascular disease among low-risk Iranians during 2 decades follow-up.
    Tohidi M; Asgari S; Chary A; Azizi F; Hadaegh F
    Clin Biochem; 2022; 109-110():28-36. PubMed ID: 35970222
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Predictive value of brachial flow-mediated dilation for incident cardiovascular events in a population-based study: the multi-ethnic study of atherosclerosis.
    Yeboah J; Folsom AR; Burke GL; Johnson C; Polak JF; Post W; Lima JA; Crouse JR; Herrington DM
    Circulation; 2009 Aug; 120(6):502-9. PubMed ID: 19635967
    [TBL] [Abstract][Full Text] [Related]  

  • 17. On-treatment non-high-density lipoprotein cholesterol, apolipoprotein B, triglycerides, and lipid ratios in relation to residual vascular risk after treatment with potent statin therapy: JUPITER (justification for the use of statins in prevention: an intervention trial evaluating rosuvastatin).
    Mora S; Glynn RJ; Boekholdt SM; Nordestgaard BG; Kastelein JJ; Ridker PM
    J Am Coll Cardiol; 2012 Apr; 59(17):1521-8. PubMed ID: 22516441
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Role of non-high-density lipoprotein cholesterol in predicting cerebrovascular events in patients following myocardial infarction.
    Mahajan N; Ference BA; Arora N; Madhavan R; Bhattacharya P; Sudhakar R; Sagar A; Wang Y; Sacks F; Afonso L
    Am J Cardiol; 2012 Jun; 109(12):1694-9. PubMed ID: 22465317
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Altered triglyceride glucose index and fasted serum triglyceride high-density lipoprotein cholesterol ratio predict incidence of cardiovascular disease in the Mashhad cohort study.
    Mirshafiei H; Darroudi S; Ghayour-Mobarhan M; Esmaeili H; AkbariRad M; Mouhebati M; Ferns GA
    Biofactors; 2022 May; 48(3):643-650. PubMed ID: 35044705
    [TBL] [Abstract][Full Text] [Related]  

  • 20. High-Density Lipoprotein Anti-Inflammatory Capacity and Incident Cardiovascular Events.
    Jia C; Anderson JLC; Gruppen EG; Lei Y; Bakker SJL; Dullaart RPF; Tietge UJF
    Circulation; 2021 May; 143(20):1935-1945. PubMed ID: 33840204
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.